Brief: Scienture Announces Issuance Of Orange Book-Listable Patent Covering Rezenopy™, The Highest Dosage Naloxone Hcl Nasal Spray Approved By The FDA For Life-Saving Opioid Overdose Emergency Treatment
14/01/2026 13:15
Jan 14 (Reuters) - Scienture Holdings Inc SCNX.O: SCIENTURE ANNOUNCES ISSUANCE OF ORANGE BOOK-LISTABLE PATENT COVERING REZENOPY™, THE HIGHEST DOSAGE NALOXONE HCL NASAL SPRAY APPROVED BY THE FDA FOR LIFE-SAVING OPIOID OVERDOSE EMERGENCY TREATMENT Source text: ID:nGNX6Gb5KF Further company coverage: SCNX.O ((Reuters.Briefs@thomsonreuters.com;))